-
Pfizer's US $5.2 billion purchase of creboro ointment and its application for listing in China
Time of Update: 2020-02-11
On February 10, Pfizer's application for listing creborough ointment in China was accepted by CDE Crisaborole is a non steroidal PDE4 inhibitor obtained by Pfizer in May 2016 for us $5.2 billion to ac
-
Review 4 important approvals passed by FDA in January 2020
Time of Update: 2020-02-06
Drug name: palforzia Pharmaceutical company: aimmune therapeutics Indications: it is suitable for children and adolescents aged 4 to 17 who are allergic to peanuts, and it is used to reduce the possib
-
Sichuan Guowei Pharmaceutical Co., Ltd.'s first imitation of "dutasteride soft capsule" was approved
Time of Update: 2020-01-20
In vernacular On January 16, Sichuan Guowei Pharmaceutical Co., Ltd declared dutasteride soft capsules according to the new 4 categories, which was approved by the State Food and Drug Administration f
-
With repeated failures and battles, tisley's innovative traditional Chinese medicine ushered in new progress in FDA
Time of Update: 2018-12-21
On December 21, Tianshili Pharmaceutical Group Co., Ltd (hereinafter referred to as "Tianshili") announced that it had received the approval letter from the U.S Food and Drug Administration (FDA) on T
-
Puli pharmaceutical expands its production capacity to build an international leading enterprise of pharmaceutical preparations
Time of Update: 2017-04-06
[China Pharmaceutical network enterprise news] Puli pharmaceutical is an early high-tech enterprise engaged in the research, development, production and sales of international generic drugs in China I
-
FDA approved Velcade for multiple myeloma (mm) retreatment
Time of Update: 2014-08-11
Source: Takeda and its subsidiary Millennium announced on August 9, 2014 that Velcade (universal name: Bortezomib) has been approved by FDA for multiple myeloma (multiple myeloma) that once responded
-
U.S. Senator wants FDA to disclose biosimilar naming policy
Time of Update: 2014-08-07
Source: China Council for the promotion of drugs 2014-08-07, a week after the US Food and Drug Administration (FDA) received the first application for approval of biosimilars, several US senators have
-
Alexion pharmaceutical: awarded the title of soliris orphan drug by FDA
Time of Update: 2014-01-22
Source: China Association for the promotion of drugs January 22, 2014 Eastern time January 21, 2014 morning, alexion pharmaceutical announced that the U.S Food and Drug Administration (FDA) agreed to